Key result
Prehabilitation and ERAS protocols offer potential benefits in cardiac surgery, including reduced complications and shorter hospital stays, though high-quality trial data is currently lacking.
Why the study?
Prehabilitation's role in cardiac surgery remains less defined due to a lack of high-quality trial data and study variability, with widespread adoption hindered by heterogeneity and logistical constraints.
Prehabilitation and ERAS protocols have the potential to optimize patients before cardiac surgery and accelerate postoperative recovery, though high-quality trial data and standardized protocols are still needed.
No takes yet. Share an insight, caveat, or question.
Prehabilitation and ERAS may benefit frail cardiac surgery patients; hypothesis-generating review leaves implementation questions open for randomized trials.
Shuker et al. (2025) conducted a review in Cardiac surgery. Prehabilitation and Enhanced Recovery After Surgery (ERAS) protocols was evaluated. Prehabilitation and ERAS protocols offer potential benefits in cardiac surgery, including reduced complications and shorter hospital stays, though high-quality trial data is currently lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: